... anthracycline-based (AB). The cardiotoxicity of AB regimens is especially relevant in the elderly population. Therefore, we retrospectively compared survival and toxicity between elderly patients with early TNBC receiving AB or anthracycline-free (AF) adjuvant chemotherapy to evaluate whether elderly patients...

... anthracycline-based chemotherapy. To determine its prognostic versus predictive value, the impact of PITX2 DNA methylation on outcomes was studied in an untreated cohort vs. an anthracycline-treated triple-negative breast cancer (TNBC) cohort. Material and Methods: The percent DNA methylation ratio (PMR...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Adjuvant treatment Anthracyclines Breast cancer Chemotherapy Dose escalation...

...Julian Puppe; Deborah van Ooyen; Jeanne Neise; Fabinshy Thangarajah; Christian Eichler; Stefan Krämer; Roman Pfister; Peter Mallmann; Marina Wirtz; Guido Michels Summary Background: Chemotherapy with anthracyclines is associated with life-threatening electrocardiographic alterations including...

...Naoki Watanabe; Shoko Otsuka; Yoko Sasaki; Reiko Shimojima; Yoji Wani; Kaori Uchino Background: Retrospective analysis suggests that anthracycline-containing regimens may be superior to non-anthracycline-containing regimens in patients with human epidermal growth factor receptor 2 (HER2)-positive...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chemotherapy Prognosis Recurrence Breast cancer Controversies Taxanes Anthracyclines Trastuzumab Breast Care Review Article · Übersichtsarbeit Breast Care 2008;3...